MedTrace Logo

A Feasibility Study of Smoking Cessation Program in Radiation Oncology

NCT00236288 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2007-10-31

No results posted yet for this study

Summary

To test the feasibility of an intensive behavioral and pharmacologic tobacco cessation program for radiation oncology patients and their families/companions.

Conditions

  • Cancer and Tobacco Abuse

Interventions

DRUG

Bupropion and intensive behavioral therapy

To prescribe bupropion and behavioral therapy to patients and/or their families, who are currently receiving radiation.

Sponsors & Collaborators

  • Walther Cancer Institute

    collaborator OTHER

  • Indiana University School of Medicine

    lead OTHER

Principal Investigators

  • Anna McDaniel, DNS, RN, FAAN · Department of Environments for Health, Indiana University School of Nursing

Study Design

Allocation
NON_RANDOMIZED
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-10-31
Completion
2007-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00236288 on ClinicalTrials.gov